Hao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Kaiyan Feng
Department of Neurology, Maoming People’s Hospital
7 shared publicationsQiaoling Wu
The First School of Clinical Medicine, Guangdong Medical University
6 shared publicationsYizhong Li
Department of Radiology, Maoming People’s Hospital
6 shared publicationsGuofang Zeng
Department of Neurology, Maoming People’s Hospital
5 shared publicationsJiaxin Cai
Department of Neurology, Maoming People’s Hospital
5 shared publicationsJiaxin Chen
Dongguan Chang’an Hospital
5 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1854469
Deep medullary veins score is associated with idiopathic normal pressure hydrocephalus in patients with arteriolosclerotic cerebral small vessel disease
Objective: This study aimed to investigate the association between deep medullary veins (DMVs) score and comorbid idiopathic normal pressure hydrocephalus (iNPH) in patients with arteriolosclerotic cerebral small vessel disease (aCSVD), and to analyze its role as an independent associated factor. Methods: A total of 80 patients with aCSVD, 40 patients with arteriolosclerotic cerebral small vessel disease comorbid with idiopathic normal pressure hydrocephalus (aCSVD-iNPH), and 30 healthy controls were enrolled. All participants underwent 3.0-T brain MRI to assess DMVs score, periventricular white matter hyperintensity (PVWMH) volume, deep white matter hyperintensity (DWMH) volume, lacunes, cerebral microbleeds, and total CSVD burden score. Clinical and laboratory data were also collected. Multivariate logistic regression was used to identify independent associated factors, and receiver operating characteristic (ROC) curves were employed to evaluate the discriminative ability of the identified factors for group allocation. Results: The DMVs score in the aCSVD-iNPH group (15.29 ± 3.67) was significantly higher than that in the aCSVD group (11.73 ± 2.83) and the healthy control group (11.57 ± 1.79) ( P < 0.001). Multivariate logistic regression showed that DMVs score (OR = 1.499, 95%CI: 1.212–1.855, P < 0.001) and PVWMH volume (OR = 1.070, 95%CI: 1.018–1.124, P = 0.007) were independent associated factors for aCSVD-iNPH. The combined model incorporating both DMVs score and PVWMH volume achieved a higher area under the ROC curve (0.863) than either indicator alone, with a sensitivity of 72.5% and a specificity of 90.0%. Conclusion: Elevated DMVs score is associated with comorbid iNPH in aCSVD patients and serves as an independent associated factor. The combination of DMVs score and PVWMH volume may represent a promising imaging biomarker for identifying individuals with aCSVD-iNPH, pending prospective validation.
- 25 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1854469
Open AccessDeep medullary veins score is associated with idiopathic normal pressure hydrocephalus in patients with arteriolosclerotic cerebral small vessel disease
Objective: This study aimed to investigate the association between deep medullary veins (DMVs) score and comorbid idiopathic normal pressure hydrocephalus (iNPH) in patients with arteriolosclerotic cerebral small vessel disease (aCSVD), and to analyze its role as an independent associated factor. Methods: A total of 80 patients with aCSVD, 40 patients with arteriolosclerotic cerebral small vessel disease comorbid with idiopathic normal pressure hydrocephalus (aCSVD-iNPH), and 30 healthy controls were enrolled. All participants underwent 3.0-T brain MRI to assess DMVs score, periventricular white matter hyperintensity (PVWMH) volume, deep white matter hyperintensity (DWMH) volume, lacunes, cerebral microbleeds, and total CSVD burden score. Clinical and laboratory data were also collected. Multivariate logistic regression was used to identify independent associated factors, and receiver operating characteristic (ROC) curves were employed to evaluate the discriminative ability of the identified factors for group allocation. Results: The DMVs score in the aCSVD-iNPH group (15.29 ± 3.67) was significantly higher than that in the aCSVD group (11.73 ± 2.83) and the healthy control group (11.57 ± 1.79) ( P < 0.001). Multivariate logistic regression showed that DMVs score (OR = 1.499, 95%CI: 1.212–1.855, P < 0.001) and PVWMH volume (OR = 1.070, 95%CI: 1.018–1.124, P = 0.007) were independent associated factors for aCSVD-iNPH. The combined model incorporating both DMVs score and PVWMH volume achieved a higher area under the ROC curve (0.863) than either indicator alone, with a sensitivity of 72.5% and a specificity of 90.0%. Conclusion: Elevated DMVs score is associated with comorbid iNPH in aCSVD patients and serves as an independent associated factor. The combination of DMVs score and PVWMH volume may represent a promising imaging biomarker for identifying individuals with aCSVD-iNPH, pending prospective validation.
- Open Access
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1902154
Correction: Association between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).''Name of all authors as they appear in the published original article Jiaxin Cai1,2 † , Kaiyan Feng2 † , Jiaxin Chen3,4 † ,Lijuan Liang2,3 ,Qiaoling Wu2,3 ,Qishan He1,5 ,Xiong Zhang1,2,3 ,Jianming Lei6,Jianhui Mai2 ,Yizhong Li7 ,Jinwen Feng2 ,Chunnian Huang2 ,Guofang Zeng2 ,Chunwan Chen2 ,Haifeng Huang2 ,Shisheng Ye2 * and Hao Li1,2,3,8 *Grant number incorrect An incorrect number was provided for [22021087]. The correct number is [2021087]. The original version of this article has been updated.
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1902154
Open AccessCorrection: Association between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus
• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others. • Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).''Name of all authors as they appear in the published original article Jiaxin Cai1,2 † , Kaiyan Feng2 † , Jiaxin Chen3,4 † ,Lijuan Liang2,3 ,Qiaoling Wu2,3 ,Qishan He1,5 ,Xiong Zhang1,2,3 ,Jianming Lei6,Jianhui Mai2 ,Yizhong Li7 ,Jinwen Feng2 ,Chunnian Huang2 ,Guofang Zeng2 ,Chunwan Chen2 ,Haifeng Huang2 ,Shisheng Ye2 * and Hao Li1,2,3,8 *Grant number incorrect An incorrect number was provided for [22021087]. The correct number is [2021087]. The original version of this article has been updated.
- Open Access
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1865573
White matter hyperintensity drives EEG microstate abnormalities in arteriosclerotic cerebral small vessel disease
Objectives: Although MRI is the optimal imaging method for assessing white matter hyperintensity (WMH), it lacks sensitivity to the underlying pathophysiological changes of WMH. This study aims to investigate EEG changes associated with WMH and identify potential EEG biomarkers for WMH-related dementia. Methods: This cross-sectional study enrolled 90 subjects: 30 patients with WMH with dementia (WMHD), 30 patients with WMH without dementia (WMH-ND), and 30 age-and sex-matched healthy controls. Brain MRI was used to segment and quantify deep, periventricular, and total WMH volumes (DWMH, PVWMH, TWMH). Resting-state EEG data were recorded for microstate analysis. Four microstate classes (A, B, C, D) were extracted, and their occurrence, mean duration, time coverage, and transition probabilities were calculated. Partial correlation analysis was used to evaluate the associations between microstate features and WMH volume as well as MMSE scores. Based on microstate features, classification prediction models were constructed using machine learning algorithm. Results: In the WMHD group, the temporal parameters (occurrence, mean duration, time coverage) of microstate C were decreased ( P < 0.05–0.001), while the mean duration of microstates A and B was prolonged ( P < 0.05–0.001). The WMH-ND group also showed reduced microstate C temporal parameters ( P < 0.001), but exhibited compensatory increases in mean duration and time coverage of microstate D ( P < 0.001). Transition probabilities toward microstate C were reduced in both patient groups ( P < 0.001), and all transition probabilities toward microstate D were lower in WMHD than in WMH-ND ( P < 0.05–0.001). Temporal parameters of microstates A and B and transition probabilities toward them were positively correlated with WMH volume and negatively correlated with MMSE score. Conversely, those of microstate D showed the opposite correlations. For distinguishing WMHD from WMH-ND, support vector machine (SVM) and logistic regression (LR) performed best (accuracy: 76.67%, AUC: 0.84). Classification performance was highest for WMH-ND vs. HC (LR: 79.17%, AUC 0.86), and lowest for WMHD vs. HC (SVM: 68.33%, AUC 0.77). Conclusion: Patients with WMH exhibit alterations in EEG microstate features that are significantly correlated with WMH burden and cognitive function. Classification models based on these microstate features show promise for practical application in WMH-related dementia.
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1865573
Open AccessWhite matter hyperintensity drives EEG microstate abnormalities in arteriosclerotic cerebral small vessel disease
Objectives: Although MRI is the optimal imaging method for assessing white matter hyperintensity (WMH), it lacks sensitivity to the underlying pathophysiological changes of WMH. This study aims to investigate EEG changes associated with WMH and identify potential EEG biomarkers for WMH-related dementia. Methods: This cross-sectional study enrolled 90 subjects: 30 patients with WMH with dementia (WMHD), 30 patients with WMH without dementia (WMH-ND), and 30 age-and sex-matched healthy controls. Brain MRI was used to segment and quantify deep, periventricular, and total WMH volumes (DWMH, PVWMH, TWMH). Resting-state EEG data were recorded for microstate analysis. Four microstate classes (A, B, C, D) were extracted, and their occurrence, mean duration, time coverage, and transition probabilities were calculated. Partial correlation analysis was used to evaluate the associations between microstate features and WMH volume as well as MMSE scores. Based on microstate features, classification prediction models were constructed using machine learning algorithm. Results: In the WMHD group, the temporal parameters (occurrence, mean duration, time coverage) of microstate C were decreased ( P < 0.05–0.001), while the mean duration of microstates A and B was prolonged ( P < 0.05–0.001). The WMH-ND group also showed reduced microstate C temporal parameters ( P < 0.001), but exhibited compensatory increases in mean duration and time coverage of microstate D ( P < 0.001). Transition probabilities toward microstate C were reduced in both patient groups ( P < 0.001), and all transition probabilities toward microstate D were lower in WMHD than in WMH-ND ( P < 0.05–0.001). Temporal parameters of microstates A and B and transition probabilities toward them were positively correlated with WMH volume and negatively correlated with MMSE score. Conversely, those of microstate D showed the opposite correlations. For distinguishing WMHD from WMH-ND, support vector machine (SVM) and logistic regression (LR) performed best (accuracy: 76.67%, AUC: 0.84). Classification performance was highest for WMH-ND vs. HC (LR: 79.17%, AUC 0.86), and lowest for WMHD vs. HC (SVM: 68.33%, AUC 0.77). Conclusion: Patients with WMH exhibit alterations in EEG microstate features that are significantly correlated with WMH burden and cognitive function. Classification models based on these microstate features show promise for practical application in WMH-related dementia.
- Open Access
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1789687
Association between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus
Objectives: This study aims to characterize the gut microbiota in arteriosclerotic cerebral small vessel disease and idiopathic normal pressure hydrocephalus (aCSVD-iNPH) patients, investigate its correlation with cerebral small vessel disease imaging markers, and develop a diagnostic model based on differential microbial profiles. Methods: This study enrolled 95 subjects. Fresh fecal samples were collected for microbial DNA extraction. Gut microbiota composition was analyzed using 16S rDNA sequencing, and Spearman’s correlation analysis was performed to investigate the association between microbial abundance and imaging indicators. Results: An analysis of gut microbiota diversity revealed no statistically significant differences in α -diversity among the three groups, but there were significant differences in β -diversity. Compared to the aCSVD group, the relative abundances of Clostridium_Innocuum_group, Dietzia, Lachnospira, Pedobacter, Romboutsia, Saccharomyces, Solobacterium, Thermus, and TM7x were significantly higher in the aCSVD-iNPH group (all p < 0.05). Among these, the relative abundance of Solobacterium was negatively correlated with the number of cerebral microbleeds (CMBs) in the basal ganglia ( r = −0.292, FDR-adjusted p = 0.019) and deep regions ( r = −0.296, FDR-adjusted p = 0.018). Additionally, the relative abundance of Thermus was positively correlated with the deep medullary vein (DMV) score ( r = 0.271, FDR-adjusted p = 0.031). The ROC analysis yielded AUC values ranging from 0.666 to 0.716, indicating limited discriminative ability between aCSVD-iNPH and aCSVD (Thermus, AUC = 0.716, 95% CI 0.569–0.864, p = 0.006; Saccharomyces, AUC = 0.688, 95% CI 0.535–0.842, p = 0.017; Dietzia, AUC = 0.666, 95% CI 0.512–0.821, p = 0.034). Conclusion: This study identifies distinct changes in gut microbiota among patients with aCSVD-iNPH and their associations with aCSVD imaging markers, suggesting that certain microbial taxa may serve as potential diagnostic biomarkers to distinguish aCSVD-iNPH from aCSVD, although these preliminary findings require validation in independent cohorts.
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1789687
Open AccessAssociation between gut microbiota and imaging biomarkers in arteriosclerotic cerebral small vessel disease with idiopathic normal pressure hydrocephalus
Objectives: This study aims to characterize the gut microbiota in arteriosclerotic cerebral small vessel disease and idiopathic normal pressure hydrocephalus (aCSVD-iNPH) patients, investigate its correlation with cerebral small vessel disease imaging markers, and develop a diagnostic model based on differential microbial profiles. Methods: This study enrolled 95 subjects. Fresh fecal samples were collected for microbial DNA extraction. Gut microbiota composition was analyzed using 16S rDNA sequencing, and Spearman’s correlation analysis was performed to investigate the association between microbial abundance and imaging indicators. Results: An analysis of gut microbiota diversity revealed no statistically significant differences in α -diversity among the three groups, but there were significant differences in β -diversity. Compared to the aCSVD group, the relative abundances of Clostridium_Innocuum_group, Dietzia, Lachnospira, Pedobacter, Romboutsia, Saccharomyces, Solobacterium, Thermus, and TM7x were significantly higher in the aCSVD-iNPH group (all p < 0.05). Among these, the relative abundance of Solobacterium was negatively correlated with the number of cerebral microbleeds (CMBs) in the basal ganglia ( r = −0.292, FDR-adjusted p = 0.019) and deep regions ( r = −0.296, FDR-adjusted p = 0.018). Additionally, the relative abundance of Thermus was positively correlated with the deep medullary vein (DMV) score ( r = 0.271, FDR-adjusted p = 0.031). The ROC analysis yielded AUC values ranging from 0.666 to 0.716, indicating limited discriminative ability between aCSVD-iNPH and aCSVD (Thermus, AUC = 0.716, 95% CI 0.569–0.864, p = 0.006; Saccharomyces, AUC = 0.688, 95% CI 0.535–0.842, p = 0.017; Dietzia, AUC = 0.666, 95% CI 0.512–0.821, p = 0.034). Conclusion: This study identifies distinct changes in gut microbiota among patients with aCSVD-iNPH and their associations with aCSVD imaging markers, suggesting that certain microbial taxa may serve as potential diagnostic biomarkers to distinguish aCSVD-iNPH from aCSVD, although these preliminary findings require validation in independent cohorts.
- Open Access
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1607242
Deep and periventricular white matter hyperintensities exhibit differential metabolic profiles in arteriosclerotic cerebral small vessel disease: an untargeted metabolomics study
Introduction: Although white matter hyperintensities (WMH) are radiologically classified as deep WMH (DWMH) and periventricular WMH (PVWMH) based on spatial distribution, the distinct metabolic perturbations driving their pathogenesis remain incompletely characterized.Methods: This study integrated untargeted metabolomics with MRI phenotyping to delineate metabolic perturbations of WMH in arteriosclerotic cerebral small vessel disease (aCSVD) patients (n = 30) versus controls (n = 29). Plasma metabolic profiles were analyzed using UPLC-MS. Weighted gene correlation network analysis (WGCNA) evaluated associations between metabolite clusters and clinical traits, including DWMH volume, PVWMH volume and total WMH (TWMH) volume.Results: We identified 15, 16, and 16 key metabolites meeting both differential expression and WGCNA hub criteria for DWMH, PVWMH, and TWMH, respectively. Pathway Enrichment identified α-linolenic acid and linoleic acid metabolism as common pathway perturbed across both WMH categories. Key metabolites of the pathway, including docosahexaenoic acid (DHA) and stearidonic acid (SDA), demonstrated robust inverse associations with WMH volumes in confounder-adjusted linear regression models. Notably, both WMH categories share common metabolites, particularly polyunsaturated fatty acids (PUFA), while PVWMH-specific metabolites were primarily carnitine derivatives, and DWMH-specific metabolites were prostaglandin E2 and etodolac.Conclusion: These findings offer new insights into the metabolic mechanisms underlying DWMH and PVWMH in aCSVD. However, the cross-sectional nature of the study does not allow for causal conclusions. Future longitudinal studies are needed to validate the temporal relationships between metabolic perturbations and WMH progression.
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1607242
Open AccessDeep and periventricular white matter hyperintensities exhibit differential metabolic profiles in arteriosclerotic cerebral small vessel disease: an untargeted metabolomics study
Introduction: Although white matter hyperintensities (WMH) are radiologically classified as deep WMH (DWMH) and periventricular WMH (PVWMH) based on spatial distribution, the distinct metabolic perturbations driving their pathogenesis remain incompletely characterized.Methods: This study integrated untargeted metabolomics with MRI phenotyping to delineate metabolic perturbations of WMH in arteriosclerotic cerebral small vessel disease (aCSVD) patients (n = 30) versus controls (n = 29). Plasma metabolic profiles were analyzed using UPLC-MS. Weighted gene correlation network analysis (WGCNA) evaluated associations between metabolite clusters and clinical traits, including DWMH volume, PVWMH volume and total WMH (TWMH) volume.Results: We identified 15, 16, and 16 key metabolites meeting both differential expression and WGCNA hub criteria for DWMH, PVWMH, and TWMH, respectively. Pathway Enrichment identified α-linolenic acid and linoleic acid metabolism as common pathway perturbed across both WMH categories. Key metabolites of the pathway, including docosahexaenoic acid (DHA) and stearidonic acid (SDA), demonstrated robust inverse associations with WMH volumes in confounder-adjusted linear regression models. Notably, both WMH categories share common metabolites, particularly polyunsaturated fatty acids (PUFA), while PVWMH-specific metabolites were primarily carnitine derivatives, and DWMH-specific metabolites were prostaglandin E2 and etodolac.Conclusion: These findings offer new insights into the metabolic mechanisms underlying DWMH and PVWMH in aCSVD. However, the cross-sectional nature of the study does not allow for causal conclusions. Future longitudinal studies are needed to validate the temporal relationships between metabolic perturbations and WMH progression.
- Open Access
- 6 September 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1
Correction: High homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study
- 6 September 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1
Open AccessCorrection: High homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study
- Open Access
- 21 June 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-8
High homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study
The pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) remain unclear. Homocysteine may reduce the compliance of intracranial arteries and damage the endothelial function of the blood-brain barrier (BBB), which may be the underlying mechanism of iNPH. The overlap cases between deep perforating arteriopathy (DPA) and iNPH were not rare for the shared risk factors. We aimed to investigate the relationship between serum homocysteine and iNPH in DPA. A total of 41 DPA patients with iNPH and 49 DPA patients without iNPH were included. Demographic characteristics, vascular risk factors, laboratory results, and neuroimaging data were collected. Multivariable logistic regression analysis was performed to investigate the relationship between serum homocysteine and iNPH in DPA patients. Patients with iNPH had significantly higher homocysteine levels than those without iNPH (median, 16.34 mmol/L versus 14.28 mmol/L; P = 0.002). There was no significant difference in CSVD burden scores between patients with iNPH and patients without iNPH. Univariate logistic regression analysis demonstrated that patients with homocysteine levels in the Tertile3 were more likely to have iNPH than those in the Tertile1 (OR, 4.929; 95% CI, 1.612–15.071; P = 0.005). The association remained significant after multivariable adjustment for potential confounders, including age, male, hypertension, diabetes mellitus, atherosclerotic cardiovascular disease (ASCVD) or hypercholesterolemia, and eGFR level. Our study indicated that high serum homocysteine levels were independently associated with iNPH in DPA. However, further research is needed to determine the predictive value of homocysteine and to confirm the underlying mechanism between homocysteine and iNPH.
- 21 June 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-8
Open AccessHigh homocysteine is associated with idiopathic normal pressure hydrocephalus in deep perforating arteriopathy: a cross-sectional study
The pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) remain unclear. Homocysteine may reduce the compliance of intracranial arteries and damage the endothelial function of the blood-brain barrier (BBB), which may be the underlying mechanism of iNPH. The overlap cases between deep perforating arteriopathy (DPA) and iNPH were not rare for the shared risk factors. We aimed to investigate the relationship between serum homocysteine and iNPH in DPA. A total of 41 DPA patients with iNPH and 49 DPA patients without iNPH were included. Demographic characteristics, vascular risk factors, laboratory results, and neuroimaging data were collected. Multivariable logistic regression analysis was performed to investigate the relationship between serum homocysteine and iNPH in DPA patients. Patients with iNPH had significantly higher homocysteine levels than those without iNPH (median, 16.34 mmol/L versus 14.28 mmol/L; P = 0.002). There was no significant difference in CSVD burden scores between patients with iNPH and patients without iNPH. Univariate logistic regression analysis demonstrated that patients with homocysteine levels in the Tertile3 were more likely to have iNPH than those in the Tertile1 (OR, 4.929; 95% CI, 1.612–15.071; P = 0.005). The association remained significant after multivariable adjustment for potential confounders, including age, male, hypertension, diabetes mellitus, atherosclerotic cardiovascular disease (ASCVD) or hypercholesterolemia, and eGFR level. Our study indicated that high serum homocysteine levels were independently associated with iNPH in DPA. However, further research is needed to determine the predictive value of homocysteine and to confirm the underlying mechanism between homocysteine and iNPH.